SD Biosensor, Inc.(KR:137310)
â‚©7,170.00-180.00 (-2.45%)
KR:137310
SD Biosensor, Inc. financials statements
â‚©7,170.00
At close:-180.00 (-2.45%)
Want to see KR:137310 full AI Analyst Report?
SD Biosensor, Inc. (137310) Ratios
SD Biosensor, Inc. Ratios
KR:137310's free cash flow for Q3 2026 was ₩22.48B. For the 2026 fiscal year, KR:137310's free cash flow was decreased by ₩-16.77B and operating cash flow was ₩39.25B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.65 | 5.31 | 3.01 | 8.48 | 3.31 |
| Quick Ratio | 2.17 | 4.00 | 2.40 | 7.62 | 2.89 |
| Cash Ratio | 0.79 | 1.00 | 1.50 | 6.31 | 1.13 |
| Solvency Ratio | -0.43 | 0.05 | -0.34 | 3.02 | 1.38 |
| Operating Cash Flow Ratio | 0.77 | 0.89 | -0.76 | 3.00 | 1.58 |
| Short-Term Operating Cash Flow Coverage | 1.17 | 3513.59 | -1.87 | 1978.30 | 0.00 |
| Net Current Asset Value | â‚© 324.23B | â‚© -17.79B | â‚© 7.69B | â‚© 2.20T | â‚© 1.78T |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.21 | 0.16 | 0.16 | 0.01 | 0.01 |
| Debt-to-Equity Ratio | 0.29 | 0.21 | 0.21 | 0.01 | 0.01 |
| Debt-to-Capital Ratio | 0.22 | 0.17 | 0.18 | 0.01 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.13 | 0.17 | 0.14 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.39 | 1.33 | 1.34 | 1.11 | 1.37 |
| Debt Service Coverage Ratio | 1.10 | 1.69 | -1.57 | 658.29 | 2108.77 |
| Interest Coverage Ratio | -0.77 | -0.79 | -5.04 | 1153.48 | 2791.42 |
| Debt to Market Cap | 0.60 | 0.47 | 0.46 | 0.00 | 0.00 |
| Interest Debt Per Share | 6384.07 | 5524.46 | 5891.96 | 254.50 | 261.04 |
| Net Debt to EBITDA | 5.88 | -79.96 | -0.48 | -1.44 | -0.61 |
| Profitability Margins | |||||
| Gross Profit Margin | 31.79% | 48.86% | 18.68% | 47.51% | 53.59% |
| EBIT Margin | -11.66% | -21.17% | -59.39% | 42.40% | 50.00% |
| EBITDA Margin | 7.24% | -0.77% | -38.26% | 43.79% | 48.02% |
| Operating Profit Margin | -11.66% | -7.78% | -37.84% | 39.11% | 46.55% |
| Pretax Profit Margin | -129.96% | -31.56% | -66.89% | 42.36% | 49.18% |
| Net Profit Margin | -73.38% | -14.17% | -71.33% | 31.08% | 37.15% |
| Continuous Operations Profit Margin | -73.38% | -14.13% | -71.36% | 31.08% | 37.14% |
| Net Income Per EBT | 56.46% | 44.90% | 106.63% | 73.37% | 75.55% |
| EBT Per EBIT | 1114.50% | 405.46% | 176.80% | 108.33% | 105.63% |
| Return on Assets (ROA) | -16.10% | -2.53% | -12.34% | 27.94% | 36.22% |
| Return on Equity (ROE) | -22.46% | -3.37% | -16.56% | 30.95% | 49.69% |
| Return on Capital Employed (ROCE) | -2.99% | -1.46% | -7.15% | 38.67% | 61.30% |
| Return on Invested Capital (ROIC) | -1.52% | -0.65% | -6.88% | 28.17% | 45.15% |
| Return on Tangible Assets | -26.25% | -5.49% | -25.30% | 28.53% | 36.68% |
| Earnings Yield | -48.12% | -7.83% | -36.65% | 29.84% | 19.97% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.40 | 4.26 | 4.67 | 27.08 | 14.11 |
| Payables Turnover | 9.37 | 7.21 | 16.73 | 34.01 | 10.10 |
| Inventory Turnover | 2.18 | 1.53 | 2.73 | 6.04 | 4.19 |
| Fixed Asset Turnover | 1.62 | 1.43 | 1.19 | 6.26 | 14.15 |
| Asset Turnover | 0.22 | 0.18 | 0.17 | 0.90 | 0.97 |
| Working Capital Turnover Ratio | 0.93 | 0.99 | 0.46 | 1.46 | 2.44 |
| Cash Conversion Cycle | 235.75 | 273.67 | 190.31 | 63.14 | 76.81 |
| Days of Sales Outstanding | 107.46 | 85.72 | 78.23 | 13.48 | 25.86 |
| Days of Inventory Outstanding | 167.26 | 238.58 | 133.91 | 60.40 | 87.08 |
| Days of Payables Outstanding | 38.97 | 50.64 | 21.82 | 10.73 | 36.13 |
| Operating Cycle | 274.72 | 324.30 | 212.13 | 73.87 | 112.94 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 2936.50 | 1280.88 | -2185.81 | 8788.18 | 12663.36 |
| Free Cash Flow Per Share | 2467.62 | 618.84 | -3490.98 | 5822.19 | 11645.18 |
| Dividend Paid and CapEx Coverage Ratio | 4.40 | 1.93 | -1.39 | 1.78 | 8.28 |
| Capital Expenditure Coverage Ratio | 6.26 | 1.93 | -1.67 | 2.96 | 12.44 |
| Operating Cash Flow Coverage Ratio | 0.53 | 0.26 | -0.40 | 35.92 | 49.46 |
| Operating Cash Flow to Sales Ratio | 0.50 | 0.23 | -0.37 | 0.30 | 0.42 |
| Free Cash Flow Yield | 27.73% | 6.02% | -30.33% | 19.31% | 20.83% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.08 | -12.78 | -2.73 | 3.35 | 5.01 |
| Price-to-Sales (P/S) Ratio | 1.52 | 1.81 | 1.95 | 1.04 | 1.86 |
| Price-to-Book (P/B) Ratio | 0.47 | 0.43 | 0.45 | 1.04 | 2.49 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 3.61 | 16.61 | -3.30 | 5.18 | 4.80 |
| Price-to-Operating Cash Flow Ratio | 3.03 | 8.03 | -5.27 | 3.43 | 4.41 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | 0.16 | 0.02 | -0.17 | 0.06 |
| Enterprise Value Multiple | 26.95 | -314.06 | -5.57 | 0.94 | 3.27 |
| Enterprise Value | 1.39T | 1.69T | 1.40T | 1.21T | 4.59T |
| EV to EBITDA | 26.95 | -314.06 | -5.57 | 0.94 | 3.27 |
| EV to Sales | 1.95 | 2.43 | 2.13 | 0.41 | 1.57 |
| EV to Free Cash Flow | 4.61 | 22.29 | -3.61 | 2.04 | 4.05 |
| EV to Operating Cash Flow | 3.88 | 10.77 | -5.77 | 1.35 | 3.72 |
| Tangible Book Value Per Share | 8844.34 | 6856.40 | 8039.28 | 28424.90 | 22203.98 |
| Shareholders’ Equity Per Share | 19068.77 | 23921.95 | 25470.58 | 29065.47 | 22462.24 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.44 | 0.55 | -0.07 | 0.27 | 0.26 |
| Revenue Per Share | 5836.44 | 5683.77 | 5914.47 | 28944.05 | 30044.36 |
| Net Income Per Share | -4282.70 | -805.31 | -4218.95 | 8996.76 | 11161.38 |
| Tax Burden | 0.56 | 0.45 | 1.07 | 0.73 | 0.76 |
| Interest Burden | 11.15 | 1.49 | 1.13 | 1.00 | 0.98 |
| Research & Development to Revenue | 0.11 | 0.13 | 0.10 | 0.02 | 0.01 |
| SG&A to Revenue | 0.15 | 0.12 | 0.17 | 0.03 | 0.04 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Income Quality | -0.69 | -1.59 | 0.52 | 0.98 | 1.16 |
Currency in KRW

